Putaminal abnormality on 3-T magnetic resonance imaging in early parkinsonism-predominant multiple system atrophy

Jee-Young Lee1, Ji Young Yun, Chae-Won Shin

  • 1Department of Neurology, Seoul National University Boramae Hospital, Seoul, Korea.

Journal of Neurology
|July 24, 2010
PubMed

Insights

Putaminal abnormalities on 3-T MRI can help distinguish early parkinsonism-predominant multiple system atrophy (MSA-p) from Parkinson disease (PD). A specific MRI scoring system shows high accuracy in differentiating these conditions.

Area of Science:

  • Neurology
  • Radiology
  • Medical Imaging

Background:

  • Differentiating early parkinsonism-predominant multiple system atrophy (MSA-p) from Parkinson disease (PD) is clinically challenging.
  • Accurate early diagnosis is crucial for appropriate patient management and treatment.

Purpose of the Study:

  • To assess the diagnostic utility of 3-Tesla (3T) MRI-detected putaminal abnormalities for distinguishing MSA-p from PD.
  • To correlate MRI findings with long-term clinical follow-up data.

Main Methods:

  • A cohort of 23 clinically diagnosed MSA-p and 50 PD patients underwent 3T MRI at baseline.
  • Putaminal abnormalities (atrophy, hypointensity, rim disruption) were assessed and scored.
  • Patients were followed clinically for up to 3 years to confirm diagnoses.

Main Results:

  • Putaminal abnormalities were significantly more frequent in MSA-p patients (17/17 confirmed) compared to PD patients (0/50).
  • A sum score >1 on 3T MRI demonstrated high specificity (93%) and good sensitivity (70.6%) for identifying MSA-p.
  • Patients with a sum score >1 were more likely to have their MSA-p diagnosis confirmed during follow-up.

Conclusions:

  • Putaminal abnormality on 3T MRI serves as a specific imaging biomarker for early-stage MSA-p.
  • 3T MRI findings, particularly putaminal changes, can aid in differentiating MSA-p from PD, improving diagnostic accuracy.

Related Concept Videos

Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...